Literature DB >> 11906131

The development of the plutonium lung clearance model for exposure estimation of the Mayak production association, nuclear plant workers.

Valentin F Khokhryakov1, Klara G Suslova, Vadim V Vostrotin, Sergey A Romanov, Zoya S Menshikh, Tamara I Kudryavtseva, Ronald E Filipy, Scott C Miller, Melinda P Krahenbuhl.   

Abstract

The purpose of this study was to develop a biokinetic model that uses urinary plutonium excretion rate data to estimate the plutonium accumulation in the human respiratory tract after occupational exposure. The model is based on autopsy and urinalysis data, specifically the plutonium distribution between the respiratory tract and the remainder of the body, taken from 543 former workers of a radiochemical facility at the Mayak Production Association (MPA) plant. The metabolism of plutonium was represented with a compartmental model, which considers individual exposure histories and the inherent solubility properties of industrial plutonium aerosols. The transport properties of plutonium-containing aerosols were estimated by experimentally defining their in vitro solubility. The in vitro solubilities were found by dialysis in a Ringer's solution. Analysis of the autopsy data indicated that a considerable fraction of the inhaled plutonium is systemically redistributed rapidly after inhalation. After the initial dynamic period, a three-compartment model describes the retention in the respiratory tract. One compartment describes the nuclide retained in the lungs, the second compartment describes a plutonium lung concentration that exponentially decreases with time, and the third compartment describes the concentration in the pulmonary lymph nodes. The model parameters were estimated by minimizing sum squared of the error between the tissue and bioassay data and the model results. The parameters reflect the inverse relationship between plutonium retention in lungs and the experimentally derived aerosol transportability. The model was validated by comparing the autopsy results with in vivo data for 347 cases. The validation indicates that the model parameters are unbiased. This model is being used to estimate individual levels of nuclide accumulation and to compute radiation doses based upon the urinary excretion rates.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11906131     DOI: 10.1097/00004032-200204000-00001

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  3 in total

1.  Past exposure to densely ionizing radiation leaves a unique permanent signature in the genome.

Authors:  M Prakash Hande; Tamara V Azizova; Charles R Geard; Ludmilla E Burak; Catherine R Mitchell; Valentin F Khokhryakov; Evgeny K Vasilenko; David J Brenner
Journal:  Am J Hum Genet       Date:  2003-04-04       Impact factor: 11.025

2.  Lung cancer mortality among nuclear workers of the Mayak facilities in the former Soviet Union. An updated analysis considering smoking as the main confounding factor.

Authors:  M Kreisheimer; M E Sokolnikov; N A Koshurnikova; V F Khokhryakov; S A Romanow; N S Shilnikova; P V Okatenko; E A Nekolla; A M Kellerer
Journal:  Radiat Environ Biophys       Date:  2003-07-08       Impact factor: 1.925

3.  Radiation effects on mortality from solid cancers other than lung, liver, and bone cancer in the Mayak worker cohort: 1948-2008.

Authors:  Mikhail Sokolnikov; Dale Preston; Ethel Gilbert; Sara Schonfeld; Nina Koshurnikova
Journal:  PLoS One       Date:  2015-02-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.